COMMUNIQUÉS West-GlobeNewswire

SI-BONE, Inc. Reports Financial Results for the Third Quarter 2025 and Raises 2025 Guidance
10/11/2025
Delivered ~ 21% worldwide revenue growth, ~ 5% adjusted EBITDA margin, and positive cash from operating activities in the quarter Third Quarter 2025 Financial Highlights (all comparisons are to the prior year period) [...]
Oculis Reports Q3 2025 Financial Results and Provides Company Update
10/11/2025
ZUG, Switzerland, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Oculis accelerates its portfolio development with Privosegtor moving into the PIONEER pivotal program in Acute Optic Neuritis (AON) and Non-arteritic Anterior Ischemic [...]
Oculis Reports Q3 2025 Financial Results and Provides Company Update
10/11/2025
Oculis accelerates its portfolio development with Privosegtor moving into the PIONEER pivotal program in Acute Optic Neuritis (AON) and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION) following positive FDA [...]
Assembly Biosciences Reports Third Quarter 2025 Financial Results and Recent Updates
10/11/2025
– Released positive Phase 1b interim results for long-acting helicase-primase inhibitor candidate ABI-5366 showing significant reductions in viral shedding rate and genital lesion rate in recurrent genital herpes – – [...]
Mineralys Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
10/11/2025
– Submission of New Drug Application (NDA) for lorundrostat planned for late-2025/Q1 2026 – – Completed enrollment in Explore-OSA trial; topline results anticipated in Q1 2026 – – Conference call today at 4:30 p.m. ET [...]
Zentalis Pharmaceuticals Reports Third Quarter 2025 Financial Results and Operational Progress
10/11/2025
DENALI Phase 2 trial evaluating azenosertib in patients with Cyclin E1-positive PROC remains on track with topline data anticipated by year end 2026, with the potential to support an accelerated approval, subject to FDA [...]
GenesisX Robotic Magnetic Navigation System Receives U.S. FDA Clearance
10/11/2025
ST. LOUIS, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it received U.S. Food and [...]
Beyond Air® Reports Fiscal Second Quarter 2026 Financial Results and Provides Corporate Update
10/11/2025
Increased revenue by 128% year over year (YoY) to $1.8 million Appointed Beyond Air Board member Bob Goodman as Interim Chief Commercial Officer Raised $12.0 million in debt financing; proforma cash, cash equivalents, [...]
Outset Medical Reports Third-Quarter Results
10/11/2025
SAN JOSE, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today reported [...]
NeXtGen Biologics and Lovell® Government Services Partner to Bring Innovative Advanced Wound Care Technology to Federal Healthcare Systems
10/11/2025
PENSACOLA, Fla., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Lovell ® Government Services and NeXtGen™ Biologics, Inc., a medical device company that manufactures NeoMatriX ® , announced today that they have partnered to serve [...]
IMUNON Public Webcast Highlights Resilience and Innovation in Pursuit of the First Approved Immunotherapy for Ovarian Cancer
10/11/2025
Webcast Recording and Symposium Slides Now Available LAWRENCEVILLE, N.J., Nov. 10, 2025 (GLOBE NEWSWIRE) -- IMUNON , Inc. (Nasdaq: IMNN) , a clinical-stage company in Phase 3 development with its DNA-mediated [...]
Rakovina Therapeutics to Present New Data Highlighting CNS-Penetrant ATR and PARP1 Inhibitors at the 2025 Society for Neuro-Oncology Annual Meeting
10/11/2025
VANCOUVER, British Columbia, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV)(FSE: 7JO0) a biopharmaceutical company advancing cancer therapies through AI-enabled [...]
Idorsia’s aprocitentan improved key prognostic indicators in patients with difficult-to-control hypertension
10/11/2025
New analysis from landmark Phase 3 PRECISION trial published in the Journal of Hypertension highlights aprocitentan led to improvements in dipping pattern and BP load Findings reinforce the role of aprocitentan’s novel [...]
HHS Advances Women’s Health, Removes Misleading FDA Warnings on Hormone Replacement Therapy
10/11/2025
Washington, D.C., Nov. 10, 2025 (GLOBE NEWSWIRE) -- The U.S. Department of Health and Human Services (HHS) today announced historic action to restore gold-standard science to women’s health. After more than two decades [...]
Glaucoma 360 2026: Where Science, Innovation, and Collaboration Shape the Future of Vision
10/11/2025
Annual event accelerates progress toward curing glaucoma, from groundbreaking research to emerging therapies SAN FRANCISCO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Glaucoma Research Foundation (GRF) today announced the 15th [...]
NTG Nordic Transport Group publishes interim report for Q3 2025
10/11/2025
Company announcement no. 10 – 25 10 November 2025 NTG Nordic Transport Group publishes interim report for Q3 2025 The interim report for Q3 2025 is enclosed. In connection with publication of the results for Q3 2025, a [...]
Genmab Provides Certain Information Disclosed in Connection with Proposed Private Offering of Senior Secured Notes and Senior Unsecured Notes
10/11/2025
Media Release COPENHAGEN, Denmark; November 10, 2025 Genmab A/S (“Genmab”) announced on November 10, 2025, that it and its wholly owned subsidiary Genmab Finance LLC intend to offer, subject to market and other [...]
Booking Health Announces Expanded Access to Stage 4 Lung Cancer Treatments During Lung Cancer Awareness Month
10/11/2025
Stage 4 Lung Cancer Langenfeld, Germany, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Booking Health , a global facilitator of international medical care, announced today a timely initiative aimed at improving access to advanced [...]
ACTG Presents SLIM LIVER Findings at AASLD Liver Meeting Demonstrating Improvements in Biomarkers of Cardiovascular Risk among People Living with HIV and MASLD Who Receive Semaglutide
10/11/2025
LOS ANGELES, Nov. 10, 2025 (GLOBE NEWSWIRE) -- ACTG, a global clinical trials network focused on HIV and other infectious diseases, today announced data finding that treating people living with HIV and metabolic [...]

Pages